Squarepoint Ops LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$582,578
+90.6%
274,801
+327.9%
0.00%0.0%
Q2 2023$305,682
-56.8%
64,219
-48.3%
0.00%
-66.7%
Q1 2023$708,048
-88.2%
124,219
-79.1%
0.00%
-87.5%
Q4 2022$6,005,921
+1736.7%
595,235
+4407.0%
0.02%
+1100.0%
Q2 2022$327,000
-78.3%
13,207
-48.7%
0.00%
-50.0%
Q4 2021$1,506,000
-74.0%
25,739
-73.7%
0.00%
-76.5%
Q3 2021$5,801,000
+935.9%
97,874
+1415.5%
0.02%
+750.0%
Q2 2021$560,000
-55.5%
6,458
-57.7%
0.00%
-71.4%
Q1 2021$1,259,000
+150.8%
15,269
+21.6%
0.01%0.0%
Q3 2020$502,000
-78.0%
12,553
-81.1%
0.01%
-81.1%
Q2 2020$2,284,000
+656.3%
66,579
+389.6%
0.04%
+362.5%
Q1 2020$302,000
-75.9%
13,600
-78.7%
0.01%
+14.3%
Q4 2019$1,251,000
-51.9%
63,901
-61.8%
0.01%
-69.6%
Q3 2019$2,600,000
+274.1%
167,411
+388.7%
0.02%
+228.6%
Q2 2019$695,000
-52.8%
34,258
-59.1%
0.01%
-56.2%
Q1 2019$1,472,000
+481.8%
83,773
+325.4%
0.02%
+433.3%
Q4 2018$253,000
-72.0%
19,695
-64.5%
0.00%
-72.7%
Q3 2018$905,000
+1192.9%
55,532
+387.3%
0.01%
+1000.0%
Q4 2017$70,000
-25.5%
11,397
-60.6%
0.00%
-50.0%
Q2 2017$94,000
-28.2%
28,9000.0%0.00%
-50.0%
Q1 2017$131,000
+162.0%
28,900
+44.5%
0.00%
+100.0%
Q4 2016$50,00020,0000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,073,190$26,599,00026.59%
Polaris Venture Management Co. V, L.L.C. 1,823,186$23,391,00024.97%
Casdin Capital, LLC 2,550,000$32,717,0005.60%
Redmile Group, LLC 10,359,666$132,915,0005.34%
Aquilo Capital Management, LLC 697,096$8,944,0004.33%
Eversept Partners, LP 165,000$2,116,9501.15%
Artal Group S.A. 2,150,000$27,585,0001.02%
AlpInvest Partners B.V. 26,925$345,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,654,865$21,232,0000.85%
Lisanti Capital Growth, LLC 142,760$1,832,0000.74%
View complete list of FATE THERAPEUTICS INC shareholders